iBio Announces Issuance of U.S. Patent Covering Endostatin Peptides for Treating Fibrosis
BRYAN, Texas, Nov. 24, 2020 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced that the United States Patent and Trademark Office has issued U.S. …